Alanis Therapeutics Revenue
Biotechnology Research • 
San Diego, California, United States • 1-10 Employees
$
Alanis Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Alanis Therapeutics
Robert Goodenow
Chief Executive Officer
Company overview
| Headquarters | 6162 Nancy Ridge Dr, 150, San Diego, California 92121, US |
| NAICS | 541714 |
| Employees | 1-10 |
About Alanis Therapeutics
Alanis Therapeutics Inc. is a privately held biotechnology company in San Diego, CA. As a spinout of AvantGen, we are developing an antagonist antibody to Jagged-1 that triggers Notch 1 signaling in hematopoietic stem cells that lead to AML.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Alanis Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Alanis Therapeutics has never raised funding before.
United Kingdom
Netherlands
Italy
Thailand
Poland
Frequently asked questions
Alanis Therapeutics is located in San Diego, California, US.
Alanis Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
Alanis Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Alanis Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
